Theriva™ Biologics Reports Third Quarter 2023 Operational Highlights and Financial Results
- VIRAGE, the Phase 2b clinical trial of VCN-01 in combination with chemotherapy for metastatic Pancreatic Ductal Adenocarcinoma remains on track ...
Stay updated with breaking news from Institut Catala. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- VIRAGE, the Phase 2b clinical trial of VCN-01 in combination with chemotherapy for metastatic Pancreatic Ductal Adenocarcinoma remains on track ...
A partnership comprising software company Euformatics, ViennaLab Diagnostics and Oncompass Medicine, have been awarded with one of three Phase 2 contracts to research and develop an economically sustainable liquid biopsy diagnostics solution based on DNA and RNA molecular profiling in cancer patients for a buyer consortium including some of the highest ranking European hospitals(1) from Germany, France, Italy, Spain and Belgium for the OncNGS pre-commercial procurement Consortium funded by the EU. Click to read more...
The two fossils had bite marks on them with one having a mark on the broken neck point
-Appointment expected to aid advancement of Theriva's discovery program and strengthen collaboration with the Institut Catala d'Oncologia (ICO) and the Biomedical Research Institute of Bellvitge (IDIBELL)- ROCKVILLE
-Encouraging data further supports the development of novel oncolytic adenovirus (OV) platform; Announced a peer-reviewed publication highlighting positive...